Literature DB >> 2202567

Cholelithiasis in inflammatory bowel disease. A case-control study.

D Lorusso1, S Leo, A Mossa, G Misciagna, V Guerra.   

Abstract

Cholelithiasis is considered an extraintestinal manifestation of Crohn's ileitis but has not been associated with ulcerative colitis. To evaluate if an increased risk of cholelithiasis exists in patients with ulcerative colitis, biliary ultrasonography was performed on 159 patients with inflammatory bowel disease, 114 patients with ulcerative colitis, and 45 patients with Crohn's disease. A control population of 2453 residents of the town near the authors' institute was also studied. An echographic survey of gallstones was performed on the control subjects, who participated in the Multicentrica Italiana Colelitiasi (MICOL). Seventeen patients with inflammatory bowel disease had gallstones (10.7 percent), 11 patients with ulcerative colitis had gallstones (9.6 percent), and 6 patients with Crohn's disease had gallstones (13.3 percent). In the control population, diagnosis of cholelithiasis was made in 239 subjects (9.7 percent). An estimate of the relative risk (odds ratio) of gallstones in ulcerative colitis and Crohn's disease and also in 4 subgroups formed on the basis of the extent of disease (total ulcerative colitis, partial ulcerative colitis, Crohn's disease with ileitis, Crohn's disease without ileitis) with respect to the general population was calculated using logistic regression with gallstones, sex, age, and body mass index as independent variables and inflammatory bowel disease as a dependent variable. The author's findings show an increased risk of gallstones in both patients with Crohn's disease (odds ratio = 3.6; 95 percent confidence limits = 1.2 - 10.4; P = 0.02) and patients with ulcerative colitis (odds ratio = 2.5; 95 percent confidence limits = 1.2 - 5.2; P = 0.01). The risk was highest in patients with Crohn's disease involving the distal ileum (odds ratio = 4.5; 95 percent confidence limits = 1.5 - 14.1; P = 0.009) and in patients with total ulcerative colitis extending to the cecum (odds ratio = 3.3; 95 percent confidence limits = 1.3 - 8.6; P = 0.01). These results confirm that there is an increased risk of gallstones in Crohn's ileitis but they show that there also exists an increased risk in patients with total ulcerative colitis.

Entities:  

Mesh:

Year:  1990        PMID: 2202567     DOI: 10.1007/bf02052328

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  16 in total

1.  Hepatopancreatobiliary manifestations of inflammatory bowel disease.

Authors:  Kazuhiko Nakamura; Tetsuhide Ito; Kazuhiro Kotoh; Eikichi Ihara; Haruei Ogino; Tsutomu Iwasa; Yoshimasa Tanaka; Yoichiro Iboshi; Ryoichi Takayanagi
Journal:  Clin J Gastroenterol       Date:  2012-01-06

2.  Prevalence of cholelithiasis in patients with chronic inflammatory bowel disease.

Authors:  Wolfgang Kratzer; Mark-M Haenle; Richard-A Mason; Christian von Tirpitz; Volker Kaechele
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

3.  Reply to Dai et al.

Authors:  Anders Mark-Christensen; Jacob Rosenberg; Niels Qvist; Ole Thorlacius-Ussing
Journal:  Am J Gastroenterol       Date:  2017-07       Impact factor: 10.864

4.  Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland.

Authors:  Alicja Wiercinska-Drapalo; Jerzy Jaroszewicz; Robert Flisiak; Danuta Prokopowicz
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

5.  Gallbladder bile composition in patients with Crohn 's disease.

Authors:  Annika Lapidus; Jan-Erik Akerlund; Curt Einarsson
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

Review 6.  Prevalence of Gallstones in Ulcerative Colitis and Crohn's Disease: A Systematic Review and Meta-Analysis.

Authors:  Mirza M A Baig; Shayan A Irfan; Anusha Sumbal; Ramish Sumbal; Sanjay Kumar; Junaid Ahmad; Nikhila Gandrakota; Laila Tul Qadar; Maida S Chaudhry; Azka Feroz; Muhammad Sheharyar Warraich
Journal:  Cureus       Date:  2022-06-20

Review 7.  Pancreatic disorders in inflammatory bowel disease.

Authors:  Filippo Antonini; Raffaele Pezzilli; Lucia Angelelli; Giampiero Macarri
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

8.  Staphylococcal liver abscess and acute cholecystitis in a patient with Crohn's disease receiving infliximab.

Authors:  Tushar R Patel; Kepal N Patel; Andrew H Boyarsky
Journal:  J Gastrointest Surg       Date:  2006-01       Impact factor: 3.267

9.  Liver disorders in inflammatory bowel disease.

Authors:  Victor Uko; Suraj Thangada; Kadakkal Radhakrishnan
Journal:  Gastroenterol Res Pract       Date:  2012-02-15       Impact factor: 2.260

10.  Increased risk of asymptomatic gallstones in patients with ulcerative colitis.

Authors:  Jung Hoon Ha; Young Sook Park; Choon Sik Seon; Byung Kwan Son; Sang Bong Ahn; Young Kwan Jo; Seong Hwan Kim; Yun Ju Jo; Jung Hwan Kim; Jee Hye Han; Yoon Young Jung; Sook Hee Chung
Journal:  Intest Res       Date:  2015-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.